Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

TIMELAPSE. A VR application for speeding up time passage during chemotherapy

Project description

Time-compressing virtual reality application for chemotherapy patients

Virtual reality (VR) is a technology that uses computer-generated environments to immerse users in a three-dimensional, interactive environment, creating a sense of presence and engagement. Funded by the European Research Council, the TIMELAPSE project aims to enhance the well-being of oncologic patients undergoing lengthy chemotherapy sessions using VR technology. Researchers propose to develop a VR application that accelerates subjective time perception during chemotherapy, and test its tolerability and effectiveness. The key objective of this patient-centred approach is to improve the experience of chemotherapy by seemingly making treatment time pass more quickly, which may reduce the patients' monopolising focus on their pathology.

Objective

Chemotherapy can involve lengthy treatment sessions, lasting up to several hours. Such a duration, spent in an overly medicalized setting, can induce in the patients a monopolizing focus on their pathology, which leads to a substantial decrease in their mental well-being.
One way to alleviate the impact of long chemotherapy sessions would be accelerating subjective time passage as perceived by the patients, therefore making the treatment seemingly end more quickly.
Stemming from the ERC Advanced Grant AN-ICON, the TIMELAPSE project proposes to prototype, test, and launch on the market a virtual reality (VR) application that will accelerate subjective time passage during chemotherapy. The idea, whose singular aspects were the object of previous scientific evidence, was so far not implemented comprehensively. TIMELAPSE will fill this R&D gap with unprecedented methods and targets, adopting a patient-centred approach to innovatively incorporate in the conception of the VR application the irreplaceable perspective of its end-users: the oncologic patients.
TIMELAPSE will take this idea to proof of concept by means of five subsequent phases: 1. Theoretical elaboration, to shape a theoretical hypothesis concerning what types of VR content might accelerate subjective time passage during chemotherapy; 2. Participatory design, to refine this hypothesis by incorporating the users’ perspective; 3. Production, to develop the content for the VR application, to obtain a prototype ready to be tested. 4. Assessment, to demonstrate the tolerability and effectiveness of the VR application; and 5. Pre-commercialization, to prepare the launch of the VR application on the market.
To ensure appropriate methodological tools for each phase, TIMELAPSE will rely on a collaboration between three actors: a core research group (part of the AN-ICON team); an industrial partner expert in VR applications (Khora); and a clinical partner with substantial expertise in cancer treatment (Fondazione IRCCS San Gerardo dei Tintori).

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-POC

See all projects funded under this call

Host institution

UNIVERSITA DEGLI STUDI DI MILANO
Net EU contribution
€ 80 000,00
Address
Via Festa Del Perdono 7
20122 Milano
Italy
Region
Nord-Ovest Lombardia Milano
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (3)